Inflammation and neuronal death in the motor cortex of the wobbler mouse, an ALS animal model by unknown
RESEARCH Open Access
Inflammation and neuronal death in the
motor cortex of the wobbler mouse, an
ALS animal model
Carolin Dahlke1, Darius Saberi1, Bastian Ott1, Beate Brand-Saberi3, Thomas Schmitt-John2 and Carsten Theiss1*
Abstract
Background: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder of the upper and lower
motor neurons, characterized by rapid progressive weakness, muscle atrophy, dysarthria, dysphagia, and dyspnea.
Whereas the exact cause of ALS remains uncertain, the wobbler mouse (phenotype WR; genotype wr/wr) equally
develops a progressive degeneration of motor neurons in the spinal cord and motor cortex with striking similarities
to sporadic human ALS, suggesting the possibility of a common pathway to cell death.
Methods: With the aid of immunohistochemistry, confocal laser scanning microscopy, and transmission electron
microscopy techniques, we analyze the proliferation behavior of microglial cells and astrocytes. We also investigate
possible motor neuron death in the mouse motor cortex at different stages of the wobbler disease, which so far
has not received much attention.
Results: An abnormal density of Iba-1-positive microglial cells expressing pro-inflammatory tumor necrosis factor
(TNF) alpha- and glial fibrillary acidic protein (GFAP)-positive activated astroglial cells was detected in the motor
cortex region of the WR mouse 40 days postnatal (d.p.n.). Motor neurons in the same area show caspase 3
activation indicating neurodegenerative processes, which may cause progressive paralysis of the WR mice. It could
also cause cell degeneration, such as vacuolization, dilation of the ER, and swollen mitochondria at the same time,
and support the assumption that inflammation might be an important contributing factor of motor neuron
degeneration. This would appear to be confirmed by the fact that there was no conspicuous increase of microglial
cells and astrocytes in the motor cortex of control mice at any time.
Conclusions: Activated microglial cells secrete a variety of pro-inflammatory and neurotoxic factors, such as TNF
alpha, which could initiate apoptotic processes in the affected wobbler motor neurons, as reflected by caspase 3
activation, and thus, the neuroinflammatory processes might influence or exacerbate the neurodegeneration.
Although it remains to be clarified whether the immune response is primary or secondary and how harmful or
beneficial it is in the WR motor neuron disease, anti-inflammatory treatment might be considered.
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Background
Neurodegenerative motor neuron disorders like amyo-
trophic lateral sclerosis (ALS) induce severe phenotypes
by denervation of the skeletal muscles and lead to a
rapid progressive weakness, muscle atrophy, dysarthria,
dysphagia, dyspnoea and, consequentially, death. Even
though there is no effective therapeutic treatment, apart
from life-prolonging measures like the usage of riluzole,
a significant advance has been made in the understand-
ing of possible underlying molecular mechanisms such
as oxidative stress due to mitochondrial dysfunction,
protein aggregation, impaired axonal transport, the com-
plex interplay of the several cellular effects, and neuroin-
flammation in ALS [1–6].
Chronic neuroinflammation associated with neuro-
toxicity has been well established as one of the pri-
mary pathomechanisms in numerous neurological
disorders and diseases such as Alzheimer disease (AD),
Huntington disease, Parkinson disease (PD), as well as
ALS. Inflammation describes the host of cellular and
molecular changes, including the induction of
intracellular pathways, the release of inflammatory me-
diators, and the continuous activation and inclusion of
glial and immune cells [7, 8]. Microglial cells are simi-
lar to peripheral macrophages and constitute the main
resident immune cells of the central nervous system
(CNS). Activated by cell necrosis factor, microglial
cells are able to phagocytose apoptotic cells, DNA
fragments, cellular debris, and plaques, after they have
passed through a dramatic morphological change from
anti-inflammatory and neuroprotective cells to pro-
inflammatory and neurotoxic cells [9] (Fig. 1). They
are known as important components in neurodegenera-
tive dysfunctions, specifically distinguished by increas-
ing cell loss. Beside this, activated microglial cells
secrete pro-inflammatory and neurotoxic factors like
tumor necrosis factor alpha (TNF-α), interleukin-1 beta
(IL-1β), and free radicals [8], which are reported to be
deleterious to neurons and may cause their cell death
[10]. In response to signals of damaged or degenerative
neurons and activated microglial cells, astrocytes also
become activated and are able to hinder neuron
Fig. 1 Neuroinflammatory process aging or various genetic or environmental defects may induce early damage of motor neurons. ② Resting
microglial cells and astrocytes pass a gradual activation process after sensitization by signals of the affected motor neuron. ① ATP or CX3CL1 for
example leads to ③ morphological changes and ④ secretion of pro-inflammatory factors like tumor necrosis factor, which is able to induce
systemic inflammation, apoptotic cell death, and in the end, ⑤ phagocytosis of neuronal cell debris. In neurodegenerative diseases, activated
microglial cells and reactive astrocytes engage in cytokine communication as well, while also maintaining a synergistic balance of neuroprotection
and cytotoxity for as long as possible
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regeneration as well. Neuroinflammation, as assumed in
the wobbler mutation with regard to motor neurons,
may contribute to the occurrence of neuronal dysfunc-
tion and thus leads to a number of locomotor deficits
like decreased use and strength of hind- and forelimbs.
The autosomal recessive wr/wr mutation spontan-
eously occurred in a C57BL/Fa stock of mice at the
Institute of Animal Genetics in Edinburgh and was first
described by Falconer in 1956 [11]. The wobbler muta-
tion was linked to motor neuron degeneration [12] and
constitutes an animal model for sporadic ALS. It was
mapped to the proximal end of mouse chromosome 11
[13], leading to the identification of the affected gene:
the vacuolar-vesicular protein sorting factor 54 (Vps54)
[14]. Vps54 is a component of the multi-subunit Golgi-
associated retrograde protein (GARP) complex, a tether-
ing complex that attaches endosome-derived transport
vesicles to the trans-Golgi network [15]. The wobbler
point mutation of leucine-967 to glutamine causes a
destabilization of Vps54 protein and thereby the GARP
complex [15]. The decreased GARP stability leads to im-
paired retrograde vesicle traffic and enlarged endosomal
structures in the motor neuron [3, 16]. Homozygous
(wr/wr) mice exhibit progressive locomotor impairment
with corresponding muscle atrophy, hyperreflexia, weak-
ness, cramps, and ultimately respiratory failure caused
by degenerative motor neurons in the spinal cord, brain
stem, and motor cortex, whereas the (wobbler) WR mice
show no clinical abnormalities during the first 3 weeks
after birth (pre-symptomatic period) [17, 18]. At the age
of 4 weeks to 3 months, the WR mice are conspicuous
due to a reduced body weight, slightly unsteady gait, fine
head tremor, and muscle atrophy, predominantly in the
face and forelimbs [12, 18]. Life expectancy of homozy-
gous WR mice varies from 120 days to up to 1 year,
depending on the severity and progression of symp-
toms and the mouse strain-specific genetic background
[16, 18]. The neurological phenotype highly resembles
the symptoms of human ALS and offers some indication
of a possible common pathway to cell death [15], even
though there was no record of comparable VPS54 muta-
tions in ALS patients until now [19].
Methods
Animals
C57BL/6-Vps54wr homozygous for the Vps54 spontan-
eous mutation from a C57BL/6 background [14] was
used in this study. The mice were kept at a constant
room temperature of 22 °C ± 1 °C on a 12:12-h dark-
light cycle with free access to food and water. The exact
and special treatment of the homozygous wobbler
mouse has been recently described [17]. With the aid of
the mouse brain atlas Paxinos and Franklin, the neur-
onal tissue (layer V of the motor cortex; Bregma
2.46 mm to −1.34 mm) was dissected from the WR mice
and contemporary wild-type mice (WT; C57BL/6) ran-
ging in age from 20 to 60 days postnatal (d.p.n.) Obser-
vations were done on five WR mice and five WT mice
per age group.
Ethics statement
All protocols and experiments were performed under
the terms of the German animal protection law and
were permitted by the local authorities.
Genotyping
Genomic DNA of an ear stamp (~2 mm diameter) was
compound with 2 μl KAPA Express Extract enzyme and
10 μl 10× KAPA Express Extract buffer (Peqlab 07-
KK7100-01, Erlangen, Germany), dissolved in 90 μl aqua
destilata, and heated to 75 °C for 15 min to digest the
stamps. Afterwards, the digestion enzymes were inacti-
vated by heating the samples to 95 °C for 5 min. The
wobbler (wr) and the wild-type (wt) alleles of the Vps54
gene in the mouse genome were determined by PCR
employing the KAPA2G fast hot-start genotyping mix
(Peqlab, 07-KK5621-01, Germany). For detection of
the wr allele, we used the primers Vps54-wr-forward
(5′-AGG CCT TAA AGA TCT GGA TCA-3′) and
Vps54-wr-reverse255 (5′-TGC TCC TTA CTC AGG
GAT GC-3′), whereas for the wt-allele we used
Vps54-wt-forward413 (5′-GCT TCT CTG TTG AAG
CCA CA-3′) and Vps54-wt-reverse (5′-CCC AGA
TCT CGG CCA TAT TTA-3′) (Eurofin Genomics,
Ebersberg, Germany). Amplification of DNA requires an
initial DNA denaturation and polymerase activation step
at 95 °C for 3 min, 35 cycles of DNA denaturation at
95 °C for 15 s, primer annealing at 63 °C for 15 s,
and DNA elongation at 72 °C for 20 s. Afterwards,
1.5 % (w/v) Tris-borate-EDTA agarose gel electro-
phoresis was run at 130 mA for 30 min to separate
the DNA fragments by size [17].
Immunohistochemistry and immunofluorescence
The mice were perfused with 4 % (w/v) paraformalde-
hyde (PFA) as previously reported [17]. After post-
fixation for 3 days, the brains were incubated in a
cryo-protection solution (30 % (w/v) which is sucrose
in phosphate-buffered saline (137 mM NaCl, 3 mM
KCl, 10 mM Na2HPO4, and 1 mM KH2PO4)) for
1 day. Subsequently, the brains were embedded and
oriented in tissue freezing medium (Cryoglue, SLEE,
Mayence, Germany) and were frozen and cut with a
cryotome (Leica CM 3050 S, Wetzlar, Germany) in a
chamber temperature of −24 °C, with the temperature
of the microscope slide at −17 °C. The brain sections
were collected on SuperFrost® Plus (Gerhard Mentzel,
Braunschweig, Germany) slides and dried at 37 °C for
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1 h [16]. Immunohistochemistry was performed on
the 30-μm-thick sections of the mouse motor cortex
and were washed (5′/wash) by phosphate-buffered sa-
line (PBS) three times prior to incubation with 1 % (v/v)
Triton X-100 at room temperature for 20 min to in-
crease cell membrane permeability. Afterwards, the sec-
tions were washed five times (5′/wash) and incubated
with various primary antibodies. Detection of activated
microglial cells was performed with goat anti-Iba-1
(ab5076, Abcam, UK, 1:100) in conjunction with anti-goat
IgG Cy3 (Sigma-Aldrich, Germany, 1:100) and mouse
anti-neuronal nuclei (NeuN) (MAB377B, Chemicon,
Germany, 1:100) in conjunction with anti-mouse IgG
fluorescein isothiocyanate (FITC) (F1010, Sigma-Aldrich,
1:500). Furthermore, rabbit anti-TNF-α (ab34674, Abcam,
1:100) and rabbit anti-caspase 3, (966515, Cell Signalling,
USA, 1:100) for indicating inflammation and apoptosis
were used in conjunction with anti-rabbit IgG tetra-
methylrhodamine (TRITC) (t5268, Sigma-Aldrich, 1:500).
Detection of reactive astrocytes was implemented with
mouse anti-glial fibrillary acidic protein (GFAP) (G3893,
Sigma-Aldrich, 1:100) and rabbit anti-S100 β (S2644,
Sigma- Aldrich, 1:100) and depending on the primary
antibody, treated with anti-mouse IgG FITC (F0257;
Sigma-Aldrich, 1:500) and anti-rabbit IgG TRITC (t5268;
Sigma-Aldrich, 1:500). All of the above primary antibodies
have to be absorbed overnight at room temperature in
a humidity chamber to avoid the rapid drying out of
the specimens. Following five washes (5′/wash) with
PBS and after incubation with the primary antibody,
the samples were treated with 5 % bovine serum for
30 min to block non-specific bindings. Without wash-
ing the sections after this step, secondary antibody, as
described above, was added for 2 1/2 h at room
temperature. After washing five times (5′/wash) with
PBS, the nuclear staining of the tissues was done by
incubation with DAPI (B2261, Sigma-Aldrich, 1:1000)
for 20 min. Finally, the sections were covered with
fluorescence mounting medium (S3023, Dako, Germany)
and evaluated with a Zeiss LSM510 Meta confocal laser
scanning microscope.
Electron microscopy
The mice were perfused with 2.5 % (w/v) glutaraldehyde
(GA) as previously reported [17]. After post-fixation for
3 days in 2.5 % (v/v), the GA specimens were set in PB
for 1 h and were washed in PB for 10 min in a following
step. The samples of the WR and WT mice motor cor-
tex were incubated with Dalton for 2 h and washed in
PB for 10 min after that. Following that, the samples
were dehydrate using an ascending concentration serial
incubation in ethanol and were subsequently embedded
in Epon in different ratios over night. The motor cortex
specimens were cut with an Ultracut E Reichert-Jung,
collected on Formvar coated grids, contrasted with
uranyl acetate, and analyzed with a Philips EM 420
(Philips, Holland) transmission electron microscope with
a digital CCD camera (Model 792 BioScan; Gatan, USA)
and photographic plates system processed with a Ditabis
Micron System.
Statistical analysis
Quantitative analysis was done by confocal laser scan-
ning microscopy (Zeiss LSM 510 Meta) in combination
with Zeiss ×40 oil immersion lens (Plan-Neofluar, NA
1.3). Statistical analysis on the increase of microglial
cells, TNF alpha, and caspase 3-positive neurons was
performed by the use of 90 different slices. For each ex-
periment, at least six different slices were used (WT: n 5;
WR p20: n 5; WR p40: n 5; WR p60: n 5). The statistical
significance was evaluated using the t test and t vert in
Microsoft Excel.
Results
Microglial activation, up-regulated neuroinflammation,
and worsened neuronal damage
Progression of glial activation is confirmed in this study
by staining with the anti-Iba-1 antibody (ionizing
calcium-binding adaptor molecule 1) in the motor
cortex of the WR mice aged 20–60 d.p.n. Iba-1 is a
calcium-binding protein whose expression is restricted
to microglial cells [20] and reveals the highest increase
in Iba-1-positive cells in the WR mice 40 d.p.n (Fig. 2,
Additional file 1). Based on the intense reactivity of
microglial cells in the WR mice, we predicted an up-
regulation of the pro-inflammatory cytokine, TNF-α,
whose level was also significantly increased 40 d.p.n
(Fig. 3, Additional file 2). Further immunofluorescence
study of the affected mice showed that cleaved caspase 3
was highly expressed in NeuN-positive neurons at ap-
proximately the same time of 40 d.p.n. (Fig. 3, Add-
itional file 2). Caspase 3 is traditionally known as one of
the primary effector caspases driving apoptosis and was
not detected at any time in healthy WT control mice of
equal age. Quantitative analysis gives a plot of density of
caspase 3-positive neuronal cells in the motor cortex of
the WR and WT mice 40 d.p.n. (Fig. 4a). Data show that
on an average of 1161.43 neuronal cells/mm2 in the
motor cortex of the WT mice, approximately 1.71
cells/mm2 are positive for caspase 3. In contrast, a sig-
nificant increase in caspase 3-positive cells is seen in
the motor cortex of the WR mice, with an average 408
neuronal cells/mm2 of 1000 neuronal cells/mm2. Be-
sides this, an increased number of microglial cells
positive for TNF-α in the motor cortex of the affected
and symptomatic WR mice 40 d.p.n are detected
(Fig. 4b). In comparison with that, the data show a
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significantly lowered quantity of TNF-α-positive micro-
glial cells in the motor cortex of the WT mice 40 d.p.n.
Reactive astrocytes
Astrocyte activation in degenerating motor cortices was
determined by using anti-GFAP and anti-S100 β immu-
noreactivity. S100 β is a calcium-binding protein mainly
produced and located in the cytoplasm and nucleus of
non-activated astrocytes. It exerts autocrine and para-
crine effects on neurons and glial cells. Depending on its
concentration and localisation, S100 β regulates the
cytoskeletal structure and cell proliferation, stimulates
the expression of pro-inflammatory cytokines, and may
induce apoptotic cell death if over-expressed. The stain-
ing of astrocytes and S100 β was low or moderate in
younger and asymptomatic mice (not shown) and in-
creased dramatically during the symptomatic stage at
the age of 40 d.p.n. (Fig. 5). Our results show a link
between reactive astrocytes and the expression of the
S100 β protein by co-localization in hypertrophic astro-
cytes. Astrogliosis and S100 β overexpression in the WR
mice were typically observed nearby damaged neurons
in the motor cortex, while astrocytes positive for GFAP
in the contemporary WT mice were easily identifiable
Fig. 2 Visualization of Iba-1-labeled microglial cells in the motor cortex tissue of WR and WT mice 40 d.p.n. a–c Relation of activated microglial
cells (green) and neurons labeled with neuronal nuclei antibody (red) in healthy brain tissue of WT mice. d–f Increased level of microglial cells
(green) in affected and symptomatic WR mice. Magnification (f) shows the typical slender microglial processes (green) and the phagocytosis of a
neuronal cell (red). Scale bar = 20 μm. g–i Phagocytosis of a degenerating neuron (red) by a microglial cell (green). Scale bar = 10 μm. j Increased
number/mm2 of microglial cells in the motor cortex during the progression of the disease. Error bars represent SD ±
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surrounding blood vessels, as shown in the spinal cord
and brain stem [21].
Activated microglia cells and degenerative neurons in
ultrathin sections
To confirm the previous results, we show a severe in-
crease in activated microglial cells and aggravated neur-
onal damage in the motor cortex of the affected wobbler
mice by using transmission electron microscopy (Fig. 6).
Activated microglial cells display dense chromatin, form-
ing a layer beneath the nuclear membrane, along with
having a low density of cytoplasm. In most cases, these
cells are characterized by large perikarya and slender
microglial processes, which also contain degenerating
material of unknown origin. In addition, degenerative
neurons are detectable in the motor cortex of the wob-
bler mice, showing classic features of apoptosis as well
as degenerative changes in cytoplasmic organelles such
as mitochondria, rough endoplasmic reticulum, and a
disorganized Golgi apparatus.
Discussion
Our present study demonstrates an abnormal density
of activated, i.e., morphologically modified, and up-
regulated microglial cells in the motor cortex region
of the WR mouse, as well as an abundance of tumor
necrosis factor alpha and apoptotic caspase 3-positive
neurons. Progressive neurodegeneration resulting in
microglial activation and cell loss in the thalamus,
cerebellum, and brain stem, for example, has already
been discussed in previous studies [21], whereas the
correlation of inflammation and advancing degener-
ation, as well as the mechanism by which neurons
degenerate, still remains unresolved [22]. Several lines
of research suggest an involvement of oxidative stress,
excitotoxic mechanisms, and altered protein catabolism in
Fig. 3 Tumor necrosis factor alpha (TNF-α) and Iba-1-labeled microglial cells and caspase 3-positive neuronal cells in motor cortex tissue of WR
mice 40 d.p.n. a–f Iba-1-labeled microglial cells (green) also synthesize the cytokine TNF-α (red). f Microglial cells appear yellow due to the
co-localization of Iba-1 (green) and TNF-α (red). Scale bar = 10 μm. g–i Caspase 3-positive (red) neurons labeled with NeuN (neuronal nuclei antibody)
(green). Insert in i shows a caspase 3-positive neuron undergoing apoptosis. Scale bar = 20 μm
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the cascade of events leading to neuronal degeneration
[23]. There is some evidence that activation of microglial
cells occurred in response to acute neuronal degeneration
and death [21] and also in chronic neurodegenerative dis-
eases such as Alzheimer and Parkinson diseases [24]. An
association between chronic inflammation and chronic
neurodegeneration has been found in numerous investiga-
tions of Alzheimer disease, where activated microglial cells
are closely related to amyloid beta deposits and show
increased levels of tumor necrosis factor alpha [25].
Enlarged endosomal structures positive for amyloid
precursor protein (APP) have already been identified
in the WR motor neurons of the spinal cord and brain
stem [3] and would be an interesting target for further
analysis in the WR mouse motor cortex. Impaired
vesicle trafficking might cause neuronal stress and
chronic inflammation thereafter, similar to corresponding
observations in Alzheimer disease. It remains to be seen
whether this enhanced synthesis of pro-inflammatory me-
diators is responsible for an acceleration of the disease
and the acute symptoms of chronic neurodegenerative
disease or simply the logical consequence of neuron loss
[24]. Based on this issue, some retrospective studies imply
that the immediate treatment with anti-inflammatory
drugs (i.e., non-steroidal anti-inflammatory drugs), or the
blocking of signaling pathways, may slow the onset and
progression of symptoms and positively influence the
quality of life of chronically affected patients [24–26]. It
would also be of value to investigate the role of inflamma-
tion in the case of amyotrophic lateral sclerosis as well.
Our present data present an important insight into how
microglial activation and inflammatory processes are asso-
ciated with motor neuron death in a sporadic model of
ALS and provide a clue for a novel therapeutic target that
can be modulated to delay the onset and progression of
this severe disease.
With the aid of immunohistochemistry, our study also
proves the presence of reactive astrocytes, characterized
by an up-regulated expression of GFAP and an increased
immunoreactivity for calcium-binding protein S100 β
[27] in the mouse motor cortex of the WR mice. S100 β
may have toxic functions if overexpressed [28] and has
been linked to the progression of neuronal pathology
[27]. In the SOD1 mouse spinal cord, and in cases of
ALS, astrocytes positive for S100 β were detected; how-
ever, the expression of S100 β was limited to just a few
astrocytes in WT mice and human controls [27]. In
addition, WR mice as well as human patients develop a
Fig. 4 Quantification of caspase 3- and TNF-α-positive cells in the motor cortex of WR and WT mice. a A plot of density of caspase 3-positive
neuronal cells in the motor cortex of WR and WT mice 40 d.p.n. b The number of microglial cells positive for TNF-α in the motor cortex of WR
mice 40 d.p.n is significantly increased. Data are shown as mean ±SD; p < 0.001
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typical gliosis with proliferative and hypertrophic astro-
cytes [29] in the spinal cord. This kind of reactive astro-
gliosis may be an important process leading to the
formation of a glial scar that inhibits neuronal growth
after a central nervous system injury to physically isolate
the injured area [30, 31]. Additionally, recent studies
have shown that specifically in ALS, astrocytes can in-
duce oxidative stress and motor neuron death by produ-
cing numerous toxic molecules [6, 32, 33] such as nitric
oxide or peroxynitrite [34]. It has been reported that
WR astrocytes especially display a toxic effect on neur-
onal cells in the spinal cord instead of promoting neur-
onal outgrowth [35, 36] and thus might contribute
significantly to the progression of the disease. In other
advanced stages of neurodegenerative disorders, astro-
cytes show an increased secretion of TNF-related
apoptosis-inducing ligand (TRAIL), binding to a death
receptor and initiating apoptotic cell death [37].
The glial reaction is generally a well-known conse-
quence of neuronal death in neurodegenerative diseases
such as Parkinson’s disease. Post mortem examinations
of patients demonstrated massive neuronal cell loss sur-
rounded by a severe astrogliosis and an increase of acti-
vated microglial cells, therefore strongly supporting the
hypothesis that the glial reaction may be deleterious for
damaged neurons in Parkinson disease [23]. Addition-
ally, a higher density of glial cells, pro-inflammatory
cytokines, as well as caspase proteins have been reported
in the brain and cerebrospinal fluid of Parkinson pa-
tients [38]. Activation of the TNF-α receptor transduc-
tion pathways seems to be of particular relevance for the
progression of Parkinson disease by initiating caspase 3
and caspase 8 activation and thereby inducing apoptotic
cell death.
Indeed, the glial reaction is not specific to Parkinson’s
disease, rather, it is a common phenomenon in neuro-
logical disorders. Prolonged glial cell accumulation
surrounding motor neurons in the spinal cord of wob-
bler mice, rats, and mice expressing the ALS-linked
SOD1 mutation and even in post mortem studies is
also well established to proceed the degeneration and
subsequent paralysis of affected animals and ALS pa-
tients [34, 39, 40]. In particular, microglial activation
in the spinal cord and brain stem of ALS patients and
various SOD1 mutants has been reported in numerous
studies, so that several groups had the idea to inhibit
microglial activation by using minocycline, a tetracyc-
line derivate [41]. With the aid of minocycline, they
were able to slow down the onset and progression of
disease in young mice [42], but it still remains uncer-
tain what kind of cells is influenced by minocycline.
Nevertheless, due to its beneficial effect, minocycline
is a possible therapeutical strategy [43]. A further as-
pect observed in the mutant SOD1 mouse spinal cord,
Fig. 5 Identification of reactive astrocytes in motor cortex sections of WR and WT mice 40 d.p.n. a–c GFAP-labeled astrocytes (green) strictly
co-localized (magnification) with S100 β protein (red) in the brain tissue of control mice in moderate concentration. d–f S100 β was up-regulated
(magnification) in symptomatic mice and expressed in a population of hypertrophic astrocytes. Scale bar = 20 μm
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as well as what we have shown in the motor cortex of
the wobbler mutant, is the up-regulated production of
tumor necrosis factor in adult and symptomatic SOD1
and WR microglial cells compared to control micro-
glial cells [44]. Up-regulation of the pro-inflammatory
and neurotoxic tumor necrosis factor may also play a
key role in progressive neurodegeneration and should
be considered for use in an experimental therapeutic
treatment strategy, possibly in terms of a TNF-α an-
tagonist [45]. Overall, microglial cells show a direct
toxic effect on the motor neurons of mutant SOD1
mice [46] and may be an important component in ini-
tiation of apoptotic cell death by TNF-α as described
above. However, it is likely that the progressive neur-
onal degeneration is based on the interplay of various
mechanisms. Inflammatory processes in the motor cor-
tex of a sporadic model of ALS, as mentioned above,
have not been described until now. This new context
of an impaired motor cortex as well as involuntary
movement provides another approach of effective ther-
apy, because the rapid progression of the disease is
not restricted to damaged neurons of the spinal cord,
brain stem, and cerebellum. Earlier studies have shown
that even the motor cortex lesions exert a considerable
impact on the use of limbs, manual skill, speed of
forelimb movement, fore- and hindlimb placing, reach-
ing, forelimb strength, beam walking, spatial naviga-
tion, and spatial memory [47]. Thus, anti-inflammatory
treatment targeting motor cortex areas might lead to
beneficial effects for ALS patients.
Conclusions
The main purpose of our research is to provide detailed
insights into the role of neuroinflammation in the patho-
genesis of the sporadic form of ALS. Inflammation, evi-
denced by the activation of microglia and astrocytes, is
an essential hallmark of neurodegenerative disorders and
might be a promising target of therapeutic intervention
for ALS. Understanding the roles and relationships be-
tween microglial activation, pro-inflammatory molecules,
astrocytes, and motor neurons is particularly important
for attenuating neuroinflammation in the early stages of
Fig. 6 Ultrastructure of microglia and degenerating neurons in the motor cortex of B6.B-Vps54wr/J mice. a–e Electron micrographs from
C57BL/6 J-Vps54wr/wr mice 40 d.p.n. a A typical microglial cell with dense heterochromatin lining the nuclear membrane, a narrow rim
of contrasting light cytoplasm, and slender microglial processes (arrows). b Microglial cell containing debris of unknown origin (arrow).
These morphologic features are associated with phagocytotic cells. Asterisk: tagged astrocytic process. Scale bar = 5 μm. c–e Transmission
electron micrograph of degenerating neurons. They show an irregular morphology with highly electron dense cytoplasm containing
dense vacuoles, swollen mitochondria, and a dilated ER-Golgi network (arrow). The nucleus displayed highly condensed chromatin, clustered in
peripheral bundles. Scale bar = 20 μm
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ALS, and thereby slowing the progression of the disease.
Likewise, the proven inflammatory process of neurons in
the motor cortex of the WR mice, that so far has not
received much attention, could have an impact on the
anti-inflammatory treatment of human ALS patients.
Additional files
Additional file 1: Comparison between Iba-1-labeled microglial cells
in the motor cortex of WT mice and intense symptomatic WR mice
60 d.p.n. (A–C) Relation of activated microglial cells (red) and neurons
labeled with neuronal nuclei antibody (green) in brain tissue of WT mice.
(D–F) Relation of activated microglial cells (red) and neurons labeled
with neuronal nuclei antibody (green) in the brain tissue of severely
symptomatic WR mice. (Scale bar = 20 μm). (TIF 10223 kb)
Additional file 2: Visualization of the weak staining of Iba-1- and
TNF-α-labeled microglial and caspase 3-positive neuronal cells in
motor cortex tissue of WR mice 20 d.p.n. (A–C) Relation of activated
microglial cells (red) and neurons labeled with neuronal nuclei antibody
(green) in brain tissue of non-symptomatic WR mice. (D–F) Iba-1-labeled
microglial cells (red) synthesizing the cytokine TNF-α (green). (G–H) Caspase
3-positive (red) neurons labeled with NeuN (neuronal nuclei antibody)
(green). (Scale bar = 20 μm). (TIF 15107 kb)
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